Human pregnancy

ObsEva Announces Two Cornerstone Publications Describing Clinical Trials of Nolasiban for Improving Pregnancy and Live Birth Outcomes Following IVF

Retrieved on: 
Wednesday, August 4, 2021
Reproduction, Human reproduction, Obstetrics, Fertility medicine, Cryobiology, Fertility, In vitro fertilisation, Human pregnancy, Embryo transfer, Pregnancy rate, Meta-analysis, Randomized controlled trial

The first paper, entitled Effect of the oxytocin receptor antagonist nolasiban on pregnancy rates in women undergoing embryo transfer following IVF: analysis of three randomized clinical trials (Griesinger et al), was published in the Journal of Human Reproduction.

Key Points: 
  • The first paper, entitled Effect of the oxytocin receptor antagonist nolasiban on pregnancy rates in women undergoing embryo transfer following IVF: analysis of three randomized clinical trials (Griesinger et al), was published in the Journal of Human Reproduction.
  • The study reports the results from a meta-analysis of three randomized, placebo-controlled trials showing that nolasiban increased the likelihood of live birth following IVF.
  • The analyses also showed that the effect size for nolasiban was similar for ongoing pregnancy rate and live birth rate.
  • Population pharmacokinetic analyses indicated that higher exposures of nolasiban were associated with a higher probability of pregnancy.

Global Vitrification Market Size, Share & Trends Analysis 2021-2027 by Specimen (Oocytes (Devices, Kits & Consumables), Embryo, Sperm), & End-use (IVF Clinics, Biobanks) - ResearchAndMarkets.com

Retrieved on: 
Tuesday, July 27, 2021
Biotechnology, Medical devices, Health, Science, Research, Cryobiology, Reproduction, Human reproduction, Fertility medicine, Fertility, Human pregnancy, Obstetrics, Branches of biology, In vitro fertilisation, Vitrification, Freezing, Cryopreservation

The market is expected to expand at a CAGR of 17.7% from 2021 to 2027.

Key Points: 
  • The market is expected to expand at a CAGR of 17.7% from 2021 to 2027.
  • Several experiments and investigations have been conducted to prove the efficiency of vitrification over slow freezing, leading to its increased clinical implementation.
  • Currently, most IVF clinics are using this method to freeze the eggs/embryos and deliver a higher success rate to patients, thereby driving the market.
  • This has positively favored the high revenue share of this region in the market in 2020

Men Having Babies Conferences on Surrogacy for Gay Men Will Resume for Vaccinated-Only Attendees Starting September

Retrieved on: 
Tuesday, July 27, 2021
Human pregnancy, Obstetrics, Malaysia Marine and Heavy Engineering, Surrogacy, Industry economics)

Each year, MHB travels to a number of cities across the U.S. and internationally to share a wealth of knowledge with gay men aspiring to have a child.

Key Points: 
  • Each year, MHB travels to a number of cities across the U.S. and internationally to share a wealth of knowledge with gay men aspiring to have a child.
  • They meet reputable surrogacy providers and learn about financial assistance and other resources MHB can offer.
  • For further assurance to attendees, MHB has made arrangements in its September NY conference for exhibitors and staff to be tested on-site.
  • We will continue to monitor the ever changing public health landscape, and pivot and adjust as needed."

U.S. In-Vitro Fertilization Market is Expected to Grow at a CAGR of 5.45% During the Period 2021-2026. - ResearchAndMarkets.com

Retrieved on: 
Tuesday, July 27, 2021
Parenting, Pharmaceutical, Health, Consumer, Reproduction, Human reproduction, Human pregnancy, Fertility medicine, Fertility, Demographic economics, Cryobiology, In vitro fertilisation

The "U.S. In-Vitro Fertilization (IVF) Market - Industry Outlook and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "U.S. In-Vitro Fertilization (IVF) Market - Industry Outlook and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.
  • In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this U.S. In-vitro Fertilization Market Report
    The U.S. in-vitro fertilization market by revenue is expected to grow at a CAGR of 5.45% during the period 2021-2026.
  • The following factors are likely to contribute to the growth of the U.S. in-vitro fertilization market during the forecast period:
    The study considers the present scenario of the U.S. In-vitro fertilization market and its market dynamics for the period 2020-2026.
  • 4. Who are the key players in the US in-vitro fertilization market?

deCODE genetics - New study on inheritance and fetal growth

Retrieved on: 
Monday, July 19, 2021
Branches of biology, Embryology, Reproduction, Fertility, Fetus, Zoology, Midwifery, Human pregnancy

A total of 243 fetal growth variants are reported and 141 of them were grouped into four main clusters based on separating the effect of the variant on birth weight though the maternal versus fetal genome.

Key Points: 
  • A total of 243 fetal growth variants are reported and 141 of them were grouped into four main clusters based on separating the effect of the variant on birth weight though the maternal versus fetal genome.
  • Variants that associate with risk of type 2 diabetes associate with birth weight through both the maternal and fetal genomes but in opposite directions.
  • In the mother, the risk alleles correlate with higher birth weight but when in the fetus they correlate with lower birth weight.
  • The effects of the fetal, maternal and paternal genomes on birth weight were analysed and the study further includes analysis of birth length and ponderal index.

deCODE genetics - New study on inheritance and fetal growth

Retrieved on: 
Monday, July 19, 2021
Branches of biology, Embryology, Reproduction, Fertility, Fetus, Zoology, Midwifery, Human pregnancy

A total of 243 fetal growth variants are reported and 141 of them were grouped into four main clusters based on separating the effect of the variant on birth weight though the maternal versus fetal genome.

Key Points: 
  • A total of 243 fetal growth variants are reported and 141 of them were grouped into four main clusters based on separating the effect of the variant on birth weight though the maternal versus fetal genome.
  • Variants that associate with risk of type 2 diabetes associate with birth weight through both the maternal and fetal genomes but in opposite directions.
  • In the mother, the risk alleles correlate with higher birth weight but when in the fetus they correlate with lower birth weight.
  • The effects of the fetal, maternal and paternal genomes on birth weight were analysed and the study further includes analysis of birth length and ponderal index.

University Hospitals and Leading Pregnancy App Babyscripts Announce Collaboration

Retrieved on: 
Tuesday, July 13, 2021
Women's health, Midwifery, Human pregnancy, Obstetrics, Childbirth, Motherhood, Women, Parenting

CLEVELAND, July 13, 2021 /PRNewswire-PRWeb/ -- University Hospitals and Babyscripts , the leading virtual care platform for managing obstetrics, are collaborating to provide expectant mothers access to the Babyscripts myJourney app during the entirety of their prenatal journey and beyond.

Key Points: 
  • CLEVELAND, July 13, 2021 /PRNewswire-PRWeb/ -- University Hospitals and Babyscripts , the leading virtual care platform for managing obstetrics, are collaborating to provide expectant mothers access to the Babyscripts myJourney app during the entirety of their prenatal journey and beyond.
  • This program reflects University Hospitals and Babyscripts shared commitment to reduce systemic racial and ethnic inequities in both maternal and infant outcomes in Ohio.
  • Healthcare cannot be excellent if it is not equitable," said Nancy Cossler, MD, OB-GYN, and Chief of System Quality for Obstetrics for University Hospitals.
  • Babyscripts has spent the last six years building a clinically-validated, virtual care platform to allow OBGYNs to deliver a new model of prenatal care.

Lansinoh Announces Launch of New Birth Prep & Recovery Product Line

Retrieved on: 
Wednesday, July 7, 2021
Midwifery, Childbirth, Motherhood, Medicine, Women, Human pregnancy, Postpartum period, Women's health, Breastfeeding, Pre-exposure prophylaxis, Perineal massage, Massage

ALEXANDRIA, Va., July 7, 2021 /PRNewswire/ -- Lansinoh , a global leader in breastfeeding solutions and support for over 35 years, has announced the launch of its new Birth Prep & Recovery product line, designed to support new mothers through the postpartum period.

Key Points: 
  • ALEXANDRIA, Va., July 7, 2021 /PRNewswire/ -- Lansinoh , a global leader in breastfeeding solutions and support for over 35 years, has announced the launch of its new Birth Prep & Recovery product line, designed to support new mothers through the postpartum period.
  • Motivated by this lack of support for new mothers, Lansinoh's new line includes products to help moms prepare for giving birth and to help with their post-birth recovery.
  • The five items featured in Lansinoh's new line include:
    Pre-Birth Organic Massage Oil helps pregnant women prep for the big day by conditioning skin before perineal massage.
  • "Our new Birth Prep & Recovery products are simple, safe, and backed by research and guidance from experts," said Katie Bourdillon, PhD, of Lansinoh's new product development team.

Life Whisperer launches its third global IVF clinic collaboration at ESHRE to apply Artificial Intelligence to Oocytes

Retrieved on: 
Friday, June 25, 2021
Reproduction, Human reproduction, Fertility medicine, Human pregnancy, Medical specialties, Fertility, In vitro fertilisation, Obstetrics

Life Whisperer's first two IVF products, also developed in collaboration with clinics globally, evaluate embryo quality.

Key Points: 
  • Life Whisperer's first two IVF products, also developed in collaboration with clinics globally, evaluate embryo quality.
  • Life Whisperer has one oral presentation, and four posters featuring leading global IVF clinics including Ovation Fertility USA, IVF Life Europe, and Astra Fertility Canada.
  • Life Whisperer will also be exhibiting to promote its new Life Whisperer Genetics product and invite clinics, of any size and location, to contribute to its third global collaboration for Oocytes.
  • Presagen's flagship fertility products are branded Life Whisperer and focus on the application of AI to improve IVF outcomes for couples struggling with fertility.

Life Whisperer launches its third global IVF clinic collaboration at ESHRE to apply Artificial Intelligence to Oocytes

Retrieved on: 
Friday, June 25, 2021
Reproduction, Human reproduction, Fertility medicine, Human pregnancy, Medical specialties, Fertility, In vitro fertilisation, Obstetrics

Life Whisperer's first two IVF products, also developed in collaboration with clinics globally, evaluate embryo quality.

Key Points: 
  • Life Whisperer's first two IVF products, also developed in collaboration with clinics globally, evaluate embryo quality.
  • Life Whisperer has one oral presentation, and four posters featuring leading global IVF clinics including Ovation Fertility USA, IVF Life Europe, and Astra Fertility Canada.
  • Life Whisperer will also be exhibiting to promote its new Life Whisperer Genetics product and invite clinics, of any size and location, to contribute to its third global collaboration for Oocytes.
  • Presagen's flagship fertility products are branded Life Whisperer and focus on the application of AI to improve IVF outcomes for couples struggling with fertility.